“Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report”. Dermatology Practical & Conceptual 14, no. 4 (October 30, 2024): e2024252. Accessed December 10, 2024. https://dpcj.org/index.php/dpc/article/view/4512.